Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension

OBJECTIVE: To test the hypothesis that levels of the endogenous inhibitor of NO production, asymmetric dimethylarginine (ADMA), would be greater in preterm infants with bronchopulmonary dysplasia (BPD) -associated pulmonary hypertension (PH) than in infants with BPD alone. STUDY DESIGN: A case contr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Pediatr
Päätekijät: Trittmann, Jennifer K., Peterson, Eric, Rogers, Lynette K., Chen, Bernadette, Backes, Carl H., Klebanoff, Mark A., Nelin, Leif D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4308509/
https://ncbi.nlm.nih.gov/pubmed/25311706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2014.09.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia